Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Stock Information for Immuron Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Immuron Limited

Avinger Reports Third Quarter 2024 Results
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
Avinger Reports Second Quarter 2024 Results
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
Avinger Announces Closing of up to $24 Million Public Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.